Amidst the urgent landscape of medical emergencies, Front Line Medical Technologies emerges as a beacon of hope, tirelessly dedicated to enhancing global access to bleeding control and resuscitation solutions. At the heart of their mission lies the innovative COBRA-OS^™ (Control of Bleeding, Resuscitation, Arterial Occlusion System), a life-saving tool designed to empower healthcare providers and patients alike in critical moments.

Specializing in REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) procedures, Front Line Medical Technologies revolutionizes emergency care with the COBRA-OS. This groundbreaking device, renowned for its compact size, not only expedites procedure completion but also mitigates the risk of complications. By reducing both the time required for intervention and the potential for adverse outcomes, the COBRA-OS sets a new standard for efficiency and efficacy in bleeding control and resuscitation efforts worldwide.

Empowering Critical Interventions: The COBRA-OS^® for Aortic Occlusion

The COBRA-OS^® stands as a pivotal tool in the realm of emergency medicine, offering temporary occlusion of the aorta to stabilize patients in critical situations. This controlled occlusion strategy provides invaluable time for healthcare providers to administer definitive care, significantly enhancing patient outcomes.

User-Friendly Design for Rapid Deployment: With its intuitive design, the COBRA-OS^® facilitates rapid and precise deployment, ensuring quick intervention when every second counts. Its user-friendly interface empowers healthcare professionals to swiftly respond to emergencies, minimizing delays and optimizing patient care.

Advantages of Ultra-Low Profile: Introduced through a 4 Fr sheath, the COBRA-OS^® offers numerous advantages, including ease of use, smaller arterial access sites, and a streamlined procedural workflow. This ultra-low profile design not only enhances efficiency but also reduces the risk of complications, making it an indispensable tool in critical care settings.

Strength and Stability: Despite its compact size, the COBRA-OS^® boasts exceptional stability and strength, reliably withstanding significant aortic pressures without the risk of kinking. This durability ensures consistent performance even in high-pressure environments, instilling confidence in healthcare providers during critical interventions.

Partial REBOA Capabilities: In addition to its primary function, the COBRA-OS^® offers the capability for Partial REBOA, allowing for the titration of the balloon to permit some distal blood flow to the lower limbs. This feature proves invaluable in scenarios where patients face longer transit times to definitive care, enabling healthcare providers to fine-tune control of distal blood flow as needed.

Comprehensive Kit Components: Included with the COBRA-OS^® device are essential components such as a 10 cc Sword-Handled Syringe, Access Kit, 0.018 inch floppy tip guidewire, 4 French kink-resistant sheath with excellent transition, and a 21G 7cm beveled angiographic needle. This comprehensive package ensures that healthcare providers have all the necessary tools at their disposal for successful interventions.

The COBRA-OS^® stands as a beacon of innovation, empowering healthcare professionals with the capabilities needed to save lives in critical situations. With its advanced features and user-friendly design, it continues to redefine the standard of care for aortic occlusion procedures worldwide.

Revolutionizing Hemorrhage Control

REBOA, short for Resuscitative Endovascular Balloon Occlusion of the Aorta, emerges as a crucial technique in emergency medicine for temporarily occluding the aorta through endovascular means. This life-saving procedure involves the introduction of a balloon catheter through the common femoral artery, which is then inflated in the aorta to provide internal clamping. This temporary occlusion serves as a vital bridge, allowing healthcare providers to stabilize patients and transport them to definitive care facilities.

Elevating REBOA with the COBRA-OS^®: The COBRA-OS^® aortic occlusion device stands at the forefront of redefining REBOA, offering unparalleled efficiency and effectiveness in hemorrhage control. With its innovative design and advanced features, the COBRA-OS^® sets a new standard for aortic occlusion procedures.

Streamlined Design for Enhanced Usability: At the core of the COBRA-OS^® lies its simplistic yet innovative design, boasting a sleek 4 Fr profile that enhances ease of use. This streamlined design not only facilitates smoother procedures but also incorporates novel safety parameters, ensuring optimal outcomes for patients and healthcare providers alike.

Optimized Safety Parameters: Incorporating state-of-the-art safety measures, the COBRA-OS^® prioritizes patient safety at every step of the procedure. With meticulously designed safety parameters, healthcare providers can perform REBOA with confidence, minimizing the risk of complications and ensuring optimal patient outcomes.

Discover the COBRA-OS^® Difference: Explore the revolutionary features of the COBRA-OS^® and witness firsthand how it is reshaping the landscape of REBOA procedures. From its compact profile to its intuitive design, the COBRA-OS^® offers unparalleled performance, empowering healthcare providers to deliver swift and effective hemorrhage control in critical situations.

Enhancing Maternal Care

Postpartum Hemorrhage (PPH) stands as a critical concern in maternal healthcare, marked by excessive bleeding following childbirth. This condition arises when uterine contractions fail to exert sufficient pressure on the blood vessels where the placenta was attached, leading to potentially life-threatening complications. PPH remains a leading cause of preventable maternal illness and mortality worldwide, underscoring the urgent need for effective management strategies.

Aortic Occlusion: Advanced Treatment for PPH

In cases where first-line therapies prove ineffective, advanced treatment options become imperative to mitigate the risks associated with PPH. These options encompass a spectrum of interventions, ranging from pharmacological therapies to surgical procedures such as hysterectomy. Aortic occlusion emerges as a promising approach to address pelvic bleeding and facilitate further intervention if necessary, offering renewed hope for patients facing obstetric emergencies.

COBRA-OS^®: Tailored Solution for Postpartum Females

The COBRA-OS^® aortic occlusion device stands out as a pioneering solution tailored specifically for postpartum females, who often present unique physiological characteristics. With their smaller blood vessels and hypercoagulable states, these patients require specialized care to effectively manage PPH and mitigate associated risks. The low-profile design of the COBRA-OS^® ensures optimal compatibility with the anatomical nuances of postpartum patients, offering a minimally obstructive solution that minimizes the risk of arterial thrombosis.

Asha Parekh | Co-Founder & CEO

“With the COBRA-OS leading the charge, Front Line Medical Technologies continues to redefine the boundaries of emergency medical interventions, ushering in a new era of hope and possibility for patients and practitioners alike.”